Could this be a turning point in breast cancer research?

Researchers at Queen’s University Belfast have found a new biomarker which could predict the effectiveness of a common type of chemotherapy for patients with triple negative breast cancer.

To read more about this exciting discovery, click the link below – via Breast Cancer Now

https://breastcancernow.org/news-and-blogs/news/simple-test-could-predict-response-to-anthracycline-chemotherapy-for-patients-with-%E2%80%98triple-negative%E2%80%99-breast-cancer?utm_source=facebooko&utm_medium=social&utm_campaign=news&utm_content=10042019-link&fbclid=IwAR1_8dY2gWwAG8m7h9QBj7wuEy6DY8EKdhw43n5jweYkPP646pReEphtHQs